Novel lipid nanoparticle in a mRNA cancer vaccine drives tumor control via type I IFNs and effector CD8 T cells.

Gold MJ, Millar DG, Liu J, Menon H, Karpov Y, Olsen K, Oliveira L T, Dubé C, Tran CW, Elford AR, et al.

Mol Ther Nucleic Acids. 2026 Dec 08; 37(4):103076. PMID: 42774904. Abstract